HSD44 Healthcare Resource Utilization of Severe Eosinophilic Asthma Patients Treated With Benralizumab in Real-Life: Results From the Portuguese BETREAT Study
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.1595
https://www.valueinhealthjournal.com/article/S1098-3015(23)04725-3/fulltext
Title :
HSD44 Healthcare Resource Utilization of Severe Eosinophilic Asthma Patients Treated With Benralizumab in Real-Life: Results From the Portuguese BETREAT Study
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)04725-3&doi=10.1016/j.jval.2023.09.1595
First page :
Section Title :
Open access? :
No
Section Order :
11042